Skip to main content
. 2015 Feb 26;10(2):e0118142. doi: 10.1371/journal.pone.0118142

Table 3. IOP reduction from baseline.

Studies AGV Trab WMD(Fixed)(95%CI)
No.Eyes IOPR%:MD(SD) No.Eyes IOPR%(SD)
Wilson (2003) 59 49.38(27.55) 64 49.48(25.11) -0.10[-9.44,9.24]
Im (2004) 34 46.07(30.7) 24 58.27(30.84) -12.20[-28.19,3.79]
Pakrvan (2007) 15 55.97(16.52) 15 52.58(1.06) 3.39[-6.96,13.74]
Lee (2008) 27 46.07(30.27) 24 56.19(29.12) -10.92[-23.57,1.73]
Tran (2009) 94 41.18(27.55) 94 47.73(31.82) -6.55[-15.14, 2.04]
Shen (2011) 20 71.28(24.24) 20 65.48(23.27) 5.80[-8.93,20.53]
Total 249 258 -3.04[-8.36, 2.28]
Heterogeity I2 = 25%
Test for overall effect z = 1.12 p = 0.26

IOP: intraocular pressure; IOPR%: percentage intraocular pressure reduction; CI: confidence interval; WMD: weighted mean difference; AGV: Ahmed glaucoma valve group; Trab: trabeculectomy group.